WGN Radio News Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Chicagoland • May 11, 2025
WGN Radio News Johnson & Johnson plans $55 billion in US investments over the next four years Chicagoland • Mar 21, 2025
WMAY Springfield FDA approves Eli Lilly's obesity medication for obstructive sleep apnea Central Illinois • Dec 21, 2024
WGN Radio News Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound Chicagoland • Dec 5, 2024
CLTV | Chicago FDA will reconsider decision barring copycat versions of Lilly weight loss drug Chicagoland • Oct 14, 2024
WMAY Springfield Eli Lilly to sell Zepbound directly to consumers without insurance coverage Central Illinois • Aug 27, 2024
WGN Radio Chicago New Alzheimer's drug approved by the FDA: What to know Chicagoland • Jul 4, 2024
CLTV | Chicago What doctors are saying about the new weight loss drug Zepbound Chicagoland • Nov 24, 2023
CLTV | Chicago Patients on new Eli Lilly drug lost 24% of their weight in trials Chicagoland • Jun 27, 2023
The Chicago Crusador Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetes Chicagoland • Mar 1, 2023
Lake County News Column: Lake County a good choice if Eli Lilly bolts Indy Chicagoland • Aug 22, 2022
The Chicago Crusador Pritzker eying Indiana firms after abortion law signed Chicagoland • Aug 10, 2022
Park Ridge Herald Advocate Pritzker, Lightfoot roll out welcome mat for Indiana businesses in wake of new abortion restrictions in Hoosier State Chicagoland • Aug 9, 2022
WLS 7 ABC Chicago Eli Lilly, one of Indiana's largest employers, condemns new abortion ban Chicagoland • Aug 7, 2022
WGN Radio News Not all Western companies sever ties to Russia over Ukraine Chicagoland • Mar 10, 2022
WGN Radio News US buys 600K doses of new COVID antibody awaiting clearance Chicagoland • Feb 10, 2022
WMAQ-TV NBC Chicago As More COVID Therapeutics Are Approved, Supply Remains Limited in Chicago Area Chicagoland • Jan 27, 2022
WLS 7 ABC Chicago FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron Chicagoland • Jan 25, 2022
CLTV | Chicago FDA stops use of antibody drugs that don't work against omicron Chicagoland • Jan 25, 2022
WGN Radio News FDA halts use of antibody drugs that don't work vs. omicron Chicagoland • Jan 25, 2022
WLS 7 ABC Chicago National Institutes of Health: Only one monoclonal antibody treatment is effective against omicron Chicagoland • Jan 20, 2022